本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
TORONTO, Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Holdings (Asia) Limited, has entered into a Global Product and Technology Licensing Agreement with Jiangsu Yike Regenerative Medicine Co., Ltd. ("Yike"). The agreement grants GV the worldwide rights to apply Yike's breakthrough stem cell technology, which has demonstrated significant potential in advancing treatments for diabetes and with other regenerative medicine innovations. Under the agreement, GV is authorized to utilize Yike's proprietary regenerative medicine technology platform and jointly advance the commercialization and clinical application of related products. The collaboration will focus on key areas such as stem cell therapy, anti-aging biological repair, and cellular rejuvenation: The core stem cell technology system targeting both Type 1 and Type 2 diabetes has conducted clinical trials and the results demonstrated the potential to achieve long-term remission and even complete cure, representing a significant global breakthrough in regenerative medicine and metabolic disease treatment; Integrated stem cell-based therapeutic technologies targeting for immune diseases and metabolic disorders; Technologies for cell preparation, storage, quality control, and clinical application of stem cells. GV will leverage its international commercialization network, clinical collaboration channels, and operational expertise to introduce and expand the application of these technologies across global market. Under the revenue-sharing arrangement, both parties will share returns based on actual product sales and technology commercialization achievements. Yike will primarily generate revenue from technology licensing and clinical R&D, while GV will benefit from market sales, brand operations, and global business development. Yike will continue to provide scientific leadership and technical support, ensuring the sustained competitiveness and continuous innovation of the joint technology platform. Xiyong Hou, CEO of Visionary Holdings, commented: "This global license for Yike's stem cell technology marks a major milestone in GV's global health strategy. Diabetes currently affects more than 540 million adults worldwide, with the global treatment market exceeding USD 150 billion in 2024 and continuing to grow steadily. Existing therapies primarily manage blood glucose and delay complications, but do not offer a definitive cure. Preclinical and clinical studies have shown positive results in restoring pancreatic islet function in patients with both Type 1 and Type 2 diabetes, demonstrating the potential to achieve long-term remission and even complete cure across a broad patient population. Yike's stem cell therapy has demonstrated the potential to restore pancreatic islet function and achieve long-term diabetes remission, offering new hope to millions of patients worldwide. By combining Yike's cutting-edge regenerative science with GV's global commercialization capabilities, we aim to deliver transformative medical solutions to patients worldwide. We are confident that this collaboration will not only generate meaningful health benefits but also contribute significantly to GV's revenue growth in upcoming fiscal years." Looking ahead, GV and Yike plan to further deepen their cooperation in product R&D, clinical validation, and international market expansion, while jointly exploring global certification standards for regenerative medical products. This partnership lays a strong foundation for GV's continued growth and leadership in the rapidly evolving global medical technology sector. About Visionary Holdings Inc.Visionary Holdings Inc. (Nasdaq: GV) is a technology-driven multinational enterprise focused on innovative education, AI applications, and high-tech healthcare solutions. Headquartered in Toronto, Canada, the Company operates through its subsidiaries across North America and Asia, driving technological advancement, cross-border innovation, and global health transformation. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook," "objective" and similar terms. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond GV's control, which may cause GV's actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to GV as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in GV's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. GV does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law. Contacts: Visionary Holdings Inc.Investor RelationsEmail: IR@visionary.holdings
DUBAI, UAE, Oct. 13, 2025 /PRNewswire/ -- xFusion today marked its third major appearance at GITEX Global 2025, one of the world's top three IT exhibitions, held at the Dubai World Trade Centre (DWTC). At this year's event, which gathers over 6,500 companies from more than 180 countries, xFusion is not only showcasing its acclaimed star products like the FusionServer V8 series and the FusionPoD liquid-cooled cabinet server but is also launching a new strategic vision. xFusion Booth at GITEX xFusion unveiled its "Computing + Energy" dual-driver strategy, introducing the all-new X3 8000 Intelligent Workstation and FusionWatt Smart Energy Solutions, designed to profoundly empower the digital transformation of the Middle East and Africa (MEA) region. xFusion Booth at GITEX In-House Innovation Fuels Business Hyper-Growth Headquartered in Singapore, xFusion has achieved remarkable, cross-continental growth, driven by its deep in-house R&D capabilities and technological expertise. The company's business now spans over 100 countries, serving more than 10,000 customers and collaborating with a robust ecosystem of over 24,000 global partners. At the xFusion booth (H20 B10), the full-stack AI computing infrastructure, including the FusionServer V8 series and the FusionPoD liquid-cooled cabinet server, has drawn significant attention. The FusionServer V8 stands out as the core computing engine for the era of AI agents, adaptable to diverse scenarios from general computing to intensive AI training. The FusionPoD, with its high-density integrated design and advanced liquid cooling technology, significantly reduces data center energy consumption, perfectly aligning with the global push for green, low-carbon development and serving as a benchmark for the event's "Sustainable Technology" theme. Dual Product Launch Opens New Frontiers and Extends Strategic Vision A major highlight of xFusion's presence is the launch of two new product lines, marking a significant strategic expansion from computing infrastructure to a synergistic "Computing + Energy" ecosystem: X3 8000 Intelligent Workstation: Engineered for demanding professional scenarios like high-end scientific simulation and industrial design, the X3 8000 integrates high-performance computing modules with end-to-end security encryption, providing users with powerful, low-latency, and highly reliable local computing power. FusionWatt Smart Energy Solutions: The modular intelligent charging system showcased by xFusion offers fast charging, exceptional reliability, and simplified operations and maintenance. It is adaptable to diverse scenarios, including new energy vehicle charging and commercial & industrial energy storage. This creates a virtuous cycle where computing drives energy optimization, and resilient energy supports computing upgrades. Four Years of Deep Commitment to MEA: Building an Ecosystem, Setting Industry Benchmarks Since establishing its MEA regional headquarters in December 2021, xFusion has remained committed to a core philosophy of "In the Region, For the Region" and fostering win-win partnerships. By leveraging its leading computing technology, xFusion has empowered the digital transformation of various industries, building mature, localized ecosystems with channel partners in key markets like the UAE, Saudi Arabia, and South Africa. In the UAE, xFusion actively supports government and telecom operators in building public cloud projects, advancing digital government and infrastructure to enhance public service efficiency. In education, collaborations with multiple universities have led to the construction of high-performance computing (HPC) centers, providing a powerful platform for scientific innovation and talent development. In the energy and finance sectors, xFusion has partnered with oil & gas companies and banks to build highly efficient and stable data centers, enabling digital upgrades in exploration, production, financial trading, and risk control. These key achievements have not only driven high-quality growth in the local digital economy but have also earned xFusion deep trust and recognition from regional partners. "From Dubai to Riyadh, and from Cairo to Johannesburg, xFusion's growth has always been in lockstep with the region's dynamic development," said Louis Zhao, President of xFusion International Business. "Looking ahead, xFusion will continue to deepen its investment in the MEA market, strengthen our innovation and ecosystem collaborations, and help the region achieve sustainable digital transformation and long-term growth." Homepage: https://www.xfusion.com/en LinkedIn/Facebook/X/YouTube: xFusion Global
HANGZHOU, China, Oct. 13, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN, hereinafter referred to as the "Company") today elaborated on the progress of its cryptocurrency-denominated private placement transaction. The total consideration for this transaction was settled using 100 Bitcoin. This capital operation pioneers a new paradigm combining traditional equity financing with digital assets, fully demonstrating market recognition of JZXN's strategic layout in the cryptocurrency sector. The raised funds will be exclusively allocated to two strategic directions: constructing an intelligent digital asset custody platform, and developing cutting-edge technology-based encrypted storage systems. These initiatives aim to strengthen the Company's infrastructure service capabilities in the digital economy era. Since the disclosure of the transaction framework, market response has been positive, with the Company's stock price showing a steady upward trend and maintaining a sustained premium over its closing price prior to the announcement. This trend not only reflects investor endorsement of the innovative transaction structure but also highlights strong interest from capital markets in emerging digital financial instruments. "From signing the agreement on October 7th to its current implementation phase, we have consistently prioritized balancing compliance and innovation," stated Tao Li, CEO of JZXN. "These Bitcoin-denominated funds will be primarily invested in R&D for underlying blockchain technologies, particularly in key areas like secure multiparty computation and zero-knowledge proofs, laying the foundation for building next-generation digital financial service platforms." About JZXN As a leading domestic provider of new energy infrastructure services, Jiuzi Holdings specializes in developing charging networks across third- and fourth-tier cities. Its high-power DC fast charging stations, integrated with energy storage systems, have achieved significant scaled operational advantages. Concurrently, the Company is advancing its "Smart Energy Cloud Platform" project, planning to enable intelligent interaction between charging facilities and power grid systems via Internet of Things (IoT) technology. Leveraging proceeds from this private placement, it will also initiate R&D testing for cross-border digital payment solutions, further expanding its business horizons. For more information, please visit jzxn.com.
SAN FRANCISCO, Oct. 13, 2025 /PRNewswire/ -- MediaGo, an intelligent advertising platform, today announced its official membership with IAB UK, the leading industry body for the UK's digital advertising industry. This milestone follows MediaGo's certification as an official vendor of IAB Europe's Transparency and Consent Framework (TCF), underscoring its long-standing commitment to compliance and transparency within the European market. By joining IAB UK, MediaGo expands this commitment locally, strengthening its role in the UK's digital advertising governance and ecosystem development. As part of the global IAB network, IAB UK unites more than 300 leading media owners, brands, platforms, agencies, and technology firms dedicated to fostering a sustainable digital advertising future. As a member of IAB UK, MediaGo will gain valuable opportunities to engage with industry leaders, contribute to the development of industry standards, and access cutting-edge market insights. This membership will also facilitate direct connections with top UK brands and agencies, opening doors for new business collaborations and partnerships. MediaGo remains focused on delivering tangible advertiser value through technological innovation. Its upgraded bidding solution, SmartBid 3.0, empowers advertisers with stable budget management and conversion optimization. With access to premium global media inventory, MediaGo connects advertisers to high-quality traffic across Europe, North America, Japan, and South Korea. The platform strictly adheres to GDPR requirements in Europe and has secured re-certification by TrustArc in 2025 for its GDPR compliance. MediaGo prioritizes user data privacy, leveraging advanced brand safety features and transparent data practices to provide secure, trustworthy solutions for its clients. "MediaGo is honored to join IAB UK as a member," said Catelyn Wang, Director of Global Business Development and Sales at Baidu Global Business Unit. "IAB UK plays a crucial role in advancing compliance and innovation in the UK and worldwide digital advertising ecosystem. We look forward to collaborating closely with the bureau and its members to bring MediaGo's expertise in intelligent advertising and global expansion to the UK market and to jointly promote a sustainable advertising ecosystem." Moving forward, MediaGo will actively fulfill its responsibilities as an IAB UK member. The platform will leverage the IAB UK network to deepen its ties with UK clients and partners, continuously delivering advertising solutions marked by enhanced transparency and efficiency, to help brands achieve sustained growth in the global market. About MediaGo MediaGo is a leading intelligent advertising platform. Based on deep learning algorithms, MediaGo empowers businesses of all scales, creating tangible value for companies. With 12 operational centers worldwide, MediaGo has successfully provided localized and comprehensive business growth services to over 10,000 partners.
HONG KONG, Oct. 13, 2025 /PRNewswire/ -- In a major development for China's cosmetic industry, CHANDO Group, a leading homegrown cosmetics brand, has completed a new round of financing. Harvest Capital has invested ¥300 million (over US$40 million) in this round, with global beauty giant L'Oréal also participating as an industrial partner. This historic collaboration signals the beginning of a new chapter for CHANDO Group, as it joins forces with well-known consumer funds and international industry leaders to propel the company toward high-quality, sustainable growth. Two Decades of Beauty Leadership: Building a Multi-Brand, Full Supply Chain, and Digitally-Driven Enterprise Founded in 2001, CHANDO Group has consistently adhered to its brand philosophy, "Beautiful, as you are." dedicating itself to providing consumers worldwide with affordable, high-quality products for beauty and healthy living. According to data from Frost & Sullivan, as of 2024, CHANDO is the third-largest Chinese cosmetics group by retail sales. Its flagship brand, CHANDO, has ranked among the top two Chinese beauty brands by retail sales every year from 2013 to 2024, showcasing the company's resilience across industry cycles. Over the past two decades, CHANDO Group has evolved into a comprehensive enterprise that encompasses independent raw material sourcing, R&D, and manufacturing, with a fully integrated digital operating system and efficient direct-to-consumer (DTC) channels. Leveraging its robust capabilities, the company has expanded its portfolio to include multiple brands, such as CHANDO, Perfection Research, Chunxia, Meisu, and Jichu, covering a wide range of product categories including skincare, cosmetics, personal care, men's grooming, and baby care. Technology-Driven Beauty Innovation: Consistent Breakthroughs in R&D In a highly competitive China beauty market, CHANDO Group has remained a frontrunner by relentlessly driving brand innovation through technology. The company is committed to meeting consumers' demand for products that deliver both efficacy and beauty. Amidst the rise of countless "internet celebrity" brands, CHANDO's enduring market leadership is due to its unwavering focus on long-term strategy, putting consumers at the center, and continuously investing in core business elements that create differentiated consumer experiences. Nowadays, CHANDO has a team of 154 highly skilled researchers with expertise in fields like life sciences, material sciences, and applied chemistry. The company has also formed strategic partnerships with renowned medical institutions, including Huashan Hospital and the National Children's Medical Center (Fudan University Children's Hospital). Since 2013, CHANDO has been at the forefront of microbial fermentation research, with independent research centers in locations such as Shanghai and Nyingchi, Tibet. The company has successfully developed several proprietary core ingredients, including "Ximoin," "Blue Copper Peptide," and "Space Ginseng Yeast," making it the first Chinese cosmetics company to hold independent intellectual property rights in yeast-based ingredients. In partnership with China's aerospace program, CHANDO is also exploring skincare challenges in space environments, further pushing the boundaries of skincare science. Digital Transformation: Leading Industry Innovation In addition to its innovation in R&D, CHANDO Group's sustained success is also attributed to its forward-thinking approach to industry transformation. Not satisfied with merely being a leader in offline beauty retail, the company launched its digital transformation strategy in 2019. With a "digital-driven decision-making" philosophy, CHANDO has worked to build a consumer-centric, agile, and continuously evolving organization. The company was among the first in the cosmetics industry to implement advanced digital management tools, such as "Unified Inventory" and "Cloud Stores", setting new benchmarks for the industry. CHANDO's digital strategy has enabled the company to establish an end-to-end digital business operation, including supply chain management, inventory control, production management, sales and marketing, logistics, and consumer data analysis. This comprehensive digital framework has significantly improved operational efficiency and decision-making quality, enhancing the company's overall performance. Harvest Capital's Deep Involvement: Boosting Quality and Efficiency Harvest Capital strongly aligns with CHANDO Group's development strategy, which focuses on "cultivating lifetime consumer value" and "driven by digitalization and technology." The firm values the company's solid R&D capabilities and admires the founder's entrepreneurial spirit, which emphasizes focus, continuous innovation, and organizational evolution. Since 2021, Harvest Capital has conducted in-depth research on CHANDO Group, assembling a team of professionals from various fields—including business, finance, and legal experts—to provide strategic planning, comprehensive budget management, and organizational support. Focused on improving operational efficiency, Harvest Capital has helped CHANDO establish a comprehensive budgeting system centered around ROE (return on equity). The team participates in monthly business review meetings, collaborating with internal teams to identify areas for improvement. Additionally, Harvest Capital has helped the company optimize its DTC channel investments and growth, incorporating advanced industry methodologies and best practices to improve data quality and enhance marketing efficiency. Notably, while continuing to expand its offline retail presence, CHANDO has successfully developed an effective DTC channel, with online sales now accounting for 68.8% of its revenue. The brand has performed particularly well in the rapidly growing content e-commerce sector. In 2023, based on its deep understanding of the industry and CHANDO Group, Harvest Capital provided comprehensive recommendations for the company's five-year strategic plan. These insights were well-received by CHANDO's management and have helped shape a clear roadmap for the company's high-quality development. Moving forward, Harvest Capital will continue to support CHANDO's listing and further growth, leveraging its post-investment support systems and extensive resources in the consumer sector. A Shared Vision for the Future: Building a World-Leading Beauty Group According to CBNData, China beauty brands accounted for about 55.2% of the market share in 2024, securing a dominant position. However, the market concentration of the top five brands remains in the single digits, a stark contrast to the maturity of mature markets. This signals that the industry is entering a crucial stage, transitioning from a "mass rise" to "leader concentration." In this transition, industry leaders with core technologies, full supply chain advantages, and digital capabilities will play a key role in market consolidation. Harvest Capital firmly believes that as beauty brands grow stronger, China will soon produce world-class beauty groups. Despite macroeconomic pressures, the underlying demand for beauty and self-care remains strong and stable. For the mass market, rational consumption is becoming the norm, and consumers are increasingly seeking "high-quality, affordable" products. Brands that can deeply understand consumer needs, drive supply with demand, and consistently create value for consumers by offering high-quality products will emerge as the winners in any economic cycle. With over two decades of industry experience and a strong digital transformation advantage, CHANDO Group is well-positioned to lead this trend. This collaboration is a strategic alignment based on a shared long-term vision: to build a leading beauty brand and establish a world-class enterprise. It also represents Harvest Capital's commitment to supporting China's consumption sector and empowering national brands. As Harvest Capital's founding partner and chairman, Alan Song Xiangqian, stated, "Consumption is the stabilizer and ballast of China's economy. We remain confident in the long-term growth potential of beauty brands and are committed to supporting Chinese companies like CHANDO, which are driven by technology, digitalization, and long-term vision, to become world-class national brands."
BOSTON, Oct. 13, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced at the American Society of Human Genetics Annual Meeting that it has added Houston-based Gene by Gene, a leading genetics laboratory, to its Sequencing Service Provider Program. The Complete Genomics Service Provider Program connects its customers to a network of service providers, offering access to high-quality sequencing services using Complete Genomics DNBSEQ™ sequencing platforms. "We're excited about partnering with Complete Genomics, which we believe will contribute to the growth of the sequencing market in the U.S.," said Josh Wittner, president of Gene by Gene. Having already processed more than 40,000 genomes using Complete Genomics' DNBSEQ technology, Gene by Gene is performing a wide array of sequencing applications. Over the last two years, Gene by Gene has been integral in providing feedback to the ongoing development of Complete Genomics' technology, leading not only to chemistry improvements but also to product launches such as the recently announced T7+. As part of this next phase, Gene by Gene will be early adopters of multiple T7+ units to further enable their consistent new customer adoption and continued revenue growth. "We continue to grow our Sequencing Service Provider Program, which enables customers to utilize DNBSEQ technology and receive accurate, cost-effective data quickly via our experienced partners," said Rob Tarbox, vice president of product and marketing at Complete Genomics. About Complete Genomics Complete Genomics is a pioneering life sciences company that provides novel, complete sequencing solutions including sample and library preparation, lab automation, sequencing, and data analysis. The sequencing portfolio offers a full lineup of sequencers ranging from low, medium, and high throughput capacities, all powered by its proprietary DNBSEQ technology. More than 10,900 publications are based on DNBSEQ technology across a wide array of applications. To learn more, visit completegenomics.com. * For Research Use Only. Not for use in diagnostic procedures. About Gene by Gene Gene by Gene is a world leader in genetic testing services with over 20 years of experience. Our laboratory holds accreditation from multiple agencies, including CAP, CLIA, New York State Department of Health, California Department of Public Health, and AABB. With a cutting-edge laboratory and highly trained team of experts, we are committed to excellence in the field of genetic analysis. To learn more about Gene by Gene, visit genebygene.com.
A12 藝術空間
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
